Abstract
Pretreatment with Metopirone (40 mg.) or SKF 525-A (2 mg./100 g. maternal body weight) protected aganist the embryotoxic and teratogenic actions of7-OHM-12-MBA) (2.5 mg/100 g. maternal body weight) in the Sprague-Dawley rat. At the doses administered SKF-525-A was a more efficient protector than Metopirone. The adrenocorticolytic actions of 7-OHM-12-MBA in the maternal adrenal glands were also prevented by these compounds and a close correlation existed between the degree of protection of the maternal adrenals and of the foetuses. It is suggested that the ultimate embryopathic substance is a metabolite of 7-OHM-12-MBA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Bird, C., Crawford, A., Currie, A. et al. Protection from the Embryopathic Effects of 7-Hydroxymethyl-12-Methylbenz(a)Anthracene by 2-Methyl-1,2-bis-(3-Pyridyl)-1-Propanone (Metopirone,CIBA) and β-Diethylaminoethyldiphenyl-n-Propyl Acetate (SKF 525-A). Br J Cancer 24, 548–553 (1970). https://doi.org/10.1038/bjc.1970.66
Issue Date:
DOI: https://doi.org/10.1038/bjc.1970.66